Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Neoplasms × Rocuronium × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Renal Insufficiency, Chronic 2 Uterine Prolapse 1 Urinary Tract Infections 1 Urinary Bladder Neoplasms 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pneumonia 1 Pain 1 Neutropenia 1 Neuromuscular Blockade 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Leiomyoma 1 Intraabdominal Infections 1 Intestinal Obstruction 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1

Interventions

Trastuzumab 318 Paclitaxel 299 Cyclophosphamide 280 Docetaxel 258 Capecitabine 168 Doxorubicin 159 Letrozole 153 Tamoxifen 133 Bevacizumab 109 Fulvestrant 107 Lapatinib 105 Carboplatin 101 exemestane 100 Anastrozole 100 Radiotherapy 96 Gemcitabine 90 Epirubicin 89 palbociclib 73 Vinorelbine 69 Fluorouracil 66 Surveys and Questionnaires 64 Exercise 64 pertuzumab 59 Albumin-Bound Paclitaxel 58 Filgrastim 56 Magnetic Resonance Spectroscopy 54 eribulin 52 Everolimus 49 Blood Specimen Collection 46 Taxes 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05681611 2023-10-19

Effect of Rocuronium on BIS Values

University of Padova

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡